Are you Nitrosamine Ready? Solutions for Nitrosamine Analysis
Nitrosamine Analysis Made Simple: Achieve Compliance with Shimadzu Mass Spectrometry
Nitrosamine impurities are a growing concern in the pharmaceutical industry due to their toxicity and strict regulatory limits. This webinar will showcase how Shimadzu’s high-sensitivity LC-MS and GC-MS platforms help streamline nitrosamine detection in complex matrices, reduce method development time, and ensure compliance with FDA, EMA, and ICH M7 guidelines. Through expert insights and real-world examples, you’ll learn how to implement efficient workflows for your QA/QC and R&D labs.
Learning Objectives:
- An overview of current regulatory requirements for nitrosamine testing (USP and FDA)
- Challenges in detecting nitrosamines in complex pharmaceutical matrices.
- How Shimadzu’s LC-MS and GC-MS systems deliver high sensitivity and reliable results.
- Streamlined workflows techniques to reduce analysis time.
- Real-world case studies demonstrating successful nitrosamine analysis in QA/QC and R&D.
Who should attend:
- Pharma QA/QC
- Pharma R&D
- Regulatory Affair in need to comply with nitrosamines analysis
Presenter: Kevin Wons (Market Manager - Pharma/BioPharma, Shimadzu Scientific Instruments)
Kevin is the Market Manager for Pharma/BioPharma at Shimadzu Scientific Instruments. Prior to that, Kevin worked in Analytical R&D in biopharma for over 6 years, with experience in characterization for biologics. He also has over 3 years of experience in the academia field doing neuroscience research.
